Stago Group develop products and solutions (automatic analysers, reagents, consumables, services, ...) with the goal of improving treatment for thrombosis and Haemostasis

Our Products & Services

STA®-Rivaroxaban Calibrator & STA®-Rivaroxaban Control (CE marking)

Rivaroxaban is a new oral anticoagulant, direct factor Xa inhibitor, developed by Bayer HealthCare and sold under the trade name Xarelto®. ...

In the US, Xarelto is approved for stroke prevention in AF patients and prevention of VTE in hip or knee surgery.
In total, Rivaroxaban is approved in more than 110 countries worldwide. This makes Rivaroxaban a future major player in the...

STic Expert® HIT

For every Heparin Induced Thrombocytopenia (HIT) suspicion. A rapid and specific exclusion of Heparin Induced Thrombocytopenia in 10 minute...

Patients with HIT have a very high thrombosis risk. They require alternative anticoagulant treatments which increase the bleeding risk. In the absence of a rapid and reliable laboratory assay, many clinicians simply replace heparin based on clinical...

STA®-Procoag-PPL

The only available automated test to determine the procoagulant activity of phospholipids.

Midway between plasma haemostasis and cellular haemostasis are microparticles rich in procoagulant phospholipids. Increased procoagulant activity features in many diseases, including:

cardiovascular diseases,
certain types of cancer,
inflammatory...

Asserachrom® VIIa–AT

This innovating test is an indirect marker of Tissue Factor exposure In Vivo.

Tissue Factor (TF), a potent initiator of the blood clotting time system, is an integral membrane protein present on the surface of certain cell types located outside the vasculature and on circulating microparticles.
A primary step in the coagulation...

STA Coag Connexion®*

Your connexion to coagulation expertise.

STA Coag Connexion® is the specialised software for managing and supervising Stago systems.

More Productive & Effective

Reduced response time & Optimised resources
Standardised technical validation prevents unneeded, costly repeat analysis
Real-time...

Our Values

Stago in UK

Diagnostica Stago, the worldwide leader in the field of Haemostasis is setting the standard of excellence, with cutting-edge technologies, products and customer service. United Kingdom is one of the countries where research is the most advanced in the field of coagulation and the demand for new technologies is great. In January 2005, the subsidiary Diagnostica Stago UK was opened.

Our Commitment

Stago’s first mission is to provide health professionals with reliable, powerful and innovative haemostasis diagnostic tools in looking for a way to improve prevention, understanding, diagnostic, treatment and follow-up of coagulation-related pathologies.

Events

June 27 - 30, 2012
ISTH Annual SSC Meeting

September 4 - 5, 2012
UK NEQAS for blood coagulation Annual Scientific Meeting

October 18 - 19, 2012
BSHT/UK platelet group meeting

All Events

Understanding Haemostasis

What is Haemostasis?

Did you know?

In 1977, with Bjarne Østerud, Dr. S.I. Rapaport described the activation of factor IX by factor VIIa/tissue factor complex as an additional pathway in the initiation of blood coagulation.

Careers

Recent Jobs

We don't have any job openings at the moment. Please check back later. If you would still like to apply, you are welcome to send us an unsolicited application.

Apply

Unsolicited application